Zhaohui Jin

Also affiliated with Capital Medical University, Jilin University, XinHua Hospital, WinnMed, China Rehabilitation Research Center, Mayo Clinic in Arizona

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Systemic Therapy and Sequencing Options in Advanced Hepatocellular Carcinoma”.

Systemic Therapy and Sequencing Options in Advanced Hepatocellular Carcinoma

JAMA Oncology(2020)10.1001/jamaoncol.2020.4930

N/A

0.795DataRank · unranked

200 citations

Irbaz Bin Riaz, Syed Arsalan Ahmed Naqvi, Daniel Almquist, Syeda A. Mina, Jehad Almasri +13 more

Outcomes following FGFR Inhibitor Therapy in Patients with Cholangiocarcinoma

Targeted Oncology(2022)10.1007/s11523-022-00914-w

N/A

0.330DataRank · unranked

8 citations

Vanessa Wookey, Tyler Zemla, Qian Shi, Zhaohui Jin, Steven R. Alberts +7 more

Reevaluating Disease-Free Survival as an Endpoint vs Overall Survival in Stage III Adjuvant Colon Cancer Trials

JNCI Journal of the National Cancer Institute(2021)10.1093/jnci/djab187

N/A

0DataRank · unranked

16 citations

Mohamed E. Salem, Jesse G. Dixon, Zhaohui Jin, Romain Cohen, Aimery DeGramont +16 more

Cabozantinib Following Immunotherapy in Patients with Advanced Hepatocellular Carcinoma

Cancers(2022)10.3390/cancers14215173

N/A

0DataRank · unranked

16 citations

Jennifer Gile, Mathias Earl Palmer, Tyler Zemla, Daniel H. Ahn, Tanios Bekaii‐Saab +4 more

Outcomes of Patients with Advanced Hepatocellular Carcinoma Receiving Lenvatinib following Immunotherapy: A Real World Evidence Study

Cancers(2023)10.3390/cancers15194867

N/A

0DataRank · unranked

8 citations

Jennifer Gile, Michael H. Storandt, Zhaohui Jin, Tyler Zemla, Nguyen H. Tran +2 more

Prognostic value of tumor deposits in stage III colon cancer patients, a post-hoc analysis of CALGB/SWOG 80702 phase III study.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.3_suppl.10

N/A

0DataRank · unranked

0 citations

Qian Shi, Jeffrey P. Meyers, Zhaohui Jin, Magali Svrcek, Charles S. Fuchs +14 more

Clinicopathological and molecular biological characteristics of early-onset stage II/III colorectal adenocarcinoma: An analysis of 25 studies with 47,184 patients (pts) in the adjuvant colon cancer end points (ACCENT) database.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.4099

N/A

0DataRank · unranked

1 citations

Jesse G. Dixon, Hiral D. Parekh, Steven R. Alberts, Greg Yothers, Carmen J. Allegra +15 more